CLOSE X

NEULAND LABORATORIES LTD.

NSE : NEULANDLABBSE : 524558ISIN CODE : INE794A01010Industry : Pharmaceuticals & DrugsHouse : Private
BSE19876.80180.05 (+0.91 %)
PREV CLOSE ( ) 19696.75
OPEN PRICE ( ) 19696.75
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 651
TODAY'S LOW / HIGH ( )19696.75 20040.00
52 WK LOW / HIGH ( )11500 24235.05
BSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 07-01 1984
Management Info
Davuluri Rama Mohan Rao - Chairman Davuluri Saharsh Rao - Managing Director
Registered Office

Address 11th Floor (5th Office Level),Phoenix I V Y Building, Plot No.573 A- I I I,Road No. 82, Jubilee Hills,
Hyderabad,
Telangana-500033

Phone 040-67611600 / 67611700

Email neuland@neulandlabs.com

Website www.neulandlabs.com

Registrars Details
K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE
NEWS
04Nov Neuland Laboratories informs about pre
Neuland Laboratories has informed that it enclosed copies of newspaper a..
15Sep Neuland Labs starts operations at firs
Neuland Laboratories has commenced operations at its first commercial pe..
15Sep Neuland Laboratories informs about pre
Neuland Laboratories has informed that it enclosed a Press Release title..
08Sep Neuland Lab’s Board approves Rs 126 cr
Neuland Laboratories’ Board has approved capital expenditure (capex) of..
08Sep Neuland Lab surges as its Board approv
Neuland Laboratories is currently trading at Rs. 23661.70, up by 789.35..
Financials
Rs. in Millions
QTR Sep 26 ANNUAL 26
Net Profit511.283631.05
Gross Profit 684.81 4877.34
Operating Profit 1045.546034.09
Net Sales 4496.5720229.85
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Divi's Laboratories (BSE)
 11080.25 (7.52%)
M.Cap ( in Cr)294145.82
Abbott India (BSE)
 26684.90 (1.31%)
M.Cap ( in Cr)56703.55
Procter&Gamble Healt (BSE)
 5709.90 (2.97%)
M.Cap ( in Cr)9478.08
Acutaas Chemicals (BSE)
 3929.30 (3.75%)
M.Cap ( in Cr)32169.62
CORONA Remedies (BSE)
 2531.10 (3.78%)
M.Cap ( in Cr)15480.23
Shareholding Pattern
PROMOTERS 32.26%
NON-INSTITUTION 29.55%
MUTUAL FUNDS/UTI 12.45%
FI/BANKS/INSURANCE 1.35%
GOVERNMENT 0%
FII 0%
Advisory for Investors Complaints Data October 2026 Broking Complaints Data October 2026 DP

Filing of complaints through SEBI’s online portal ‘SCORES’ and ‘SMARTODR portal’ - Easy & quick

  • > Register On SCORES / SMARTODR Portal
  • > Mandatory Details For filling Complaints on SCORES: (Name, PAN, Address, Mobile Number, Email ID)
  • > Benefits:
    • Effective communication
    • Speedy Redressal of Grievance / Dispute
  • http://scores.sebi.gov.in
  • https://smartodr.in/login
Process Flow of Complaint Redressal Mechanism

Details of Client Bank account of Badjate Stock & Shares Private Limited:

  • 1)Client Bank account Number : 01020340001341
  • 2)Name of Bank Account :
    BADJATE STOCK AND SHARES PRIVATE LIMITED - USCNB Account
  • 3)IFSC : HDFC0000102
  • 4)BRANCH : Shankar Nagar / Dharampeth Extn Nagpur
  • 5)MICR – 440240002
  • 6)Verified UPI ID for receiving Payments: badjate.rzp1.brk@validhdfc
  • 7)Click here for QR Code

Dear Investor,
As you are aware, under the rapidly evolving dynamics of financial markets, it is crucial for investors to remain updated and well-informed about various aspects of investing in securities market. In this connection, please find a link to the BSE Investor Protection Fund website where you will find some useful educative material in the form of text and videos, so as to become an informed investor.
https://www.bseipf.com/investors_education.html We believe that an educated investor is a protected investor !!!

ATTENTION INVESTORS| KYC | IPO | CLIENT BANK A/C| DIRECT ON-BOARDING FOR PMS SERVICES| SEBI PRESENTS SAMAJH SE INVESTING SIMPLE

© Badjate Group 2018

Designed, Developed & Content Powered by ●●● Accord Fintech Pvt. Ltd.